Trademarkia Logo

Canada

C$
Trademark Search in Canada
Design

View On IC.GC.CA

Design
REGISTERED

on 10 Jan 2022

Last Applicant/ Owned by

Jiangsu Ascentage Pharma Inc.

101 Room of First FloorQB3 Building, Medical City Avenue, TaizhaoJiangsu, 225300

CN

Serial Number

1882947 filed on 13th Feb 2018

Registration Number

TMA1117280 registered on 10th Jan 2022

Registration expiry Date

10th Jan 2032

Correspondent Address

SMART & BIGGAR LP

Scotia Plaza, 40 King Street West40th FloorToronto

ONTARIO

CA

M5H3Y2

Design

Trademark usage description

medicines for the treatment of cancer, tumors, blood-related diseases, lower respiratory diseases, hiv/aids, diarrheal diseases, tuberculosis, malaria Read More

Vienna Information

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 21

One letterUne lettre

27 . 3 . 1

Letters or numerals representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an objectLettres ou chiffres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet

27 . 3 . 15

Letters or numerals representing an objectLettres ou chiffres représentant un objet

17 . 5 . 1

Measures -- Note: Not including time-measuring instruments, classified in 17.1, or balances and weights, classified in 17.3.Mesures -- Note: Non compris les instruments de mesure du temps, classés en 17.1, les balances et les poids, classés en 17.3.

17 . 5 . 17

Dials of measuring instruments -- Note: Not including dials of horological instruments (17.1.1).Cadrans d'appareils de mesure -- Note: Non compris les cadrans d'horlogerie (17.1.1).

26 . 2 . 7

Semi-circles, semi-ellipsesDemi-cercles, demi-ellipses

26 . 2 . 18

Segments or sectors of circles or ellipses, semi-circles or semi-ellipses containing one or more lettersSegments ou secteurs de cercles ou ellipses, demi-cercles ou demi-ellipses contenant une ou plusieurs lettres

26 . 11 . 1

One line or one bandUne ligne ou une bande

26 . 11 . 12

Curved lines or bands (except a 26.11.13)Lignes ou bandes courbes (excepté a 26.11.13)

Classification Information

Class [005]
Medicines for the treatment of cancer, tumors, blood-related diseases, lower respiratory diseases, HIV/AIDS, diarrheal diseases, tuberculosis, malaria, measles, pertussis, tetanus, meningitis, syphilis, influenza, viral hepatitis, Hepatitis B, infectious diarrhea, rabies, Japanese encephalitis, tuberculosis, mumps, osteoarthritis, atherosclerosis diseases, arthritis, cataracts, osteoporosis, type 2 diabetes, hypertension, alzheimer's diseases, Age-Related Macular Degeneration (AMD), stroke, fibrotic diseases, Crohn's disease, and cardiovascular disease; bacterial poisons; pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, HIV/AIDS, diarrheal diseases, tuberculosis, malaria, measles, pertussis, tetanus, meningitis, syphilis, influenza, viral hepatitis, Hepatitis B, infectious diarrhea, rabies, Japanese encephalitis, tuberculosis, mumps, osteoarthritis, atherosclerosis diseases, arthritis, cataracts, osteoporosis, type 2 diabetes, hypertension, alzheimer's diseases, Age-Related Macular Degeneration (AMD), stroke, fibrotic diseases, Crohn's disease, and cardiovascular disease; chemico-pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, HIV/AIDS, diarrheal diseases, tuberculosis, malaria, measles, pertussis, tetanus, meningitis, syphilis, influenza, viral hepatitis, Hepatitis B, infectious diarrhea, rabies, Japanese encephalitis, tuberculosis, mumps, osteoarthritis, atherosclerosis diseases, arthritis, cataracts, osteoporosis, type 2 diabetes, hypertension, alzheimer's diseases, Age-Related Macular Degeneration (AMD), stroke, fibrotic diseases, Crohn's disease, and cardiovascular disease; drugs for medical purposes in the nature of prescription apoptosis targeted compounds, next-generation kinase inhibitors and senolytic drugs; drugs for the treatment of cancer, tumors, blood-related diseases, HIV/AIDS, diarrheal diseases, tuberculosis, malaria, measles, pertussis, tetanus, meningitis, syphilis, influenza, viral hepatitis, Hepatitis B, infectious diarrhea, rabies, Japanese encephalitis, tuberculosis, mumps, osteoarthritis, atherosclerosis diseases, arthritis, cataracts, osteoporosis, type 2 diabetes, hypertension, alzheimer's diseases, Age-Related Macular Degeneration (AMD), stroke, fibrotic diseases, Crohn's disease, and cardiovascular disease; biological preparations for the treatment of cancer, tumors, blood-related diseases, HIV/AIDS, diarrheal diseases, tuberculosis, malaria, measles, pertussis, tetanus, meningitis, syphilis, influenza, viral hepatitis, Hepatitis B, infectious diarrhea, rabies, Japanese encephalitis, tuberculosis, mumps, osteoarthritis, atherosclerosis diseases, arthritis, cataracts, osteoporosis, type 2 diabetes, hypertension, alzheimer's diseases, Age-Related Macular Degeneration (AMD), stroke, fibrotic diseases, Crohn's disease, and cardiovascular disease; chemical preparations for pharmaceutical or medical purposes, namely, for use in the treatment of cancer, tumors, blood-related diseases, HIV/AIDS, diarrheal diseases, tuberculosis, malaria, measles, pertussis, tetanus, meningitis, syphilis, influenza, viral hepatitis, Hepatitis B, infectious diarrhea, rabies, Japanese encephalitis, tuberculosis, mumps, osteoarthritis, atherosclerosis diseases, arthritis, cataracts, osteoporosis, type 2 diabetes, hypertension, alzheimer's diseases, Age-Related Macular Degeneration (AMD), stroke, fibrotic diseases, Crohn's disease, and cardiovascular disease; pharmaceutical preparations for the treatment of dental and oral diseases; botanicals for the treatment of dental and oral diseases; homeopathic remedies for the treatment of dental oral diseases; antibiotics; pharmaceutical preparations in the form of injection for the treatment of cancer, tumors, blood-related diseases, HIV/AIDS, diarrheal diseases, tuberculosis, malaria, measles, pertussis, tetanus, meningitis, syphilis, influenza, viral hepatitis, Hepatitis B, infectious diarrhea, rabies, Japanese encephalitis, tuberculosis, mumps, osteoarthritis, atherosclerosis diseases, arthritis, cataracts, osteoporosis, type 2 diabetes, hypertension, alzheimer's diseases, Age-Related Macular Degeneration (AMD), stroke, fibrotic diseases, Crohn's disease, and cardiovascular disease; pharmaceutical preparations in the form of tablet for the treatment of cancer, tumors, blood-related diseases, HIV/AIDS, diarrheal diseases, tuberculosis, malaria, measles, pertussis, tetanus, meningitis, syphilis, influenza, viral hepatitis, Hepatitis B, infectious diarrhea, rabies, Japanese encephalitis, tuberculosis, mumps, osteoarthritis, atherosclerosis diseases, arthritis, cataracts, osteoporosis, type 2 diabetes, hypertension, alzheimer's diseases, Age-Related Macular Degeneration (AMD), stroke, fibrotic diseases, Crohn's disease, and cardiovascular disease; active pharmaceutical ingredients in the nature of drug delivery agents in the form of powders, liquids, and capsules that provide controlled release of active ingredients for a wide variety of pharmaceuticals; active pharmaceutical ingredients for the treatment of cancer, tumors, blood-related diseases, HIV/AIDS, diarrheal diseases, tuberculosis, malaria, measles, pertussis, tetanus, meningitis, syphilis, influenza, viral hepatitis, Hepatitis B, infectious diarrhea, rabies, Japanese encephalitis, tuberculosis, mumps, osteoarthritis, atherosclerosis diseases, arthritis, cataracts, osteoporosis, type 2 diabetes, hypertension, alzheimer's diseases, Age-Related Macular Degeneration (AMD), stroke, fibrotic diseases, Crohn's disease, and cardiovascular disease; biochemical medicines for the treatment of cancer, tumors, blood-related diseases, HIV/AIDS, diarrheal diseases, tuberculosis, malaria, measles, pertussis, tetanus, meningitis, syphilis, influenza, viral hepatitis, Hepatitis B, infectious diarrhea, rabies, Japanese encephalitis, tuberculosis, mumps, osteoarthritis, atherosclerosis diseases, arthritis, cataracts, osteoporosis, type 2 diabetes, hypertension, alzheimer's diseases, Age-Related Macular Degeneration (AMD), stroke, fibrotic diseases, Crohn's disease, and cardiovascular disease; antiseptics; collyrium; suppositories for the treatment of cancer, tumors, blood-related diseases, HIV/AIDS, diarrheal diseases, tuberculosis, malaria, measles, pertussis, tetanus, meningitis, syphilis, influenza, viral hepatitis, Hepatitis B, infectious diarrhea, rabies, Japanese encephalitis, tuberculosis, mumps, osteoarthritis, atherosclerosis diseases, arthritis, cataracts, osteoporosis, type 2 diabetes, hypertension, alzheimer's diseases, Age-Related Macular Degeneration (AMD), stroke, fibrotic diseases, Crohn's disease, and cardiovascular disease; medicinal oils for the treatment of cancer, tumors, blood-related diseases, HIV/AIDS, diarrheal diseases, tuberculosis, malaria, measles, pertussis, tetanus, meningitis, syphilis, influenza, viral hepatitis, Hepatitis B, infectious diarrhea, rabies, Japanese encephalitis, tuberculosis, mumps, osteoarthritis, atherosclerosis diseases, arthritis, cataracts, osteoporosis, type 2 diabetes, hypertension, alzheimer's diseases, Age-Related Macular Degeneration (AMD), stroke, fibrotic diseases, Crohn's disease, and cardiovascular disease; transdermal patches for use in the treatment of cancer, tumors, blood-related diseases, HIV/AIDS, diarrheal diseases, tuberculosis, malaria, measles, pertussis, tetanus, meningitis, syphilis, influenza, viral hepatitis, Hepatitis B, infectious diarrhea, rabies, Japanese encephalitis, tuberculosis, mumps, osteoarthritis, atherosclerosis diseases, arthritis, cataracts, osteoporosis, type 2 diabetes, hypertension, alzheimer's diseases, Age-Related Macular Degeneration (AMD), stroke, fibrotic diseases, Crohn's disease, and cardiovascular disease; diagnostic preparations for medical laboratory use; diagnostic preparations for clinical laboratory use; diagnostic biomarker reagents for medical purposes; medicated candy for the treatment of cancer, tumors, blood-related diseases, HIV/AIDS, diarrheal diseases, tuberculosis, malaria, measles, pertussis, tetanus, meningitis, syphilis, influenza, viral hepatitis, Hepatitis B, infectious diarrhea, rabies, Japanese encephalitis, tuberculosis, mumps, osteoarthritis, atherosclerosis diseases, arthritis, cataracts, osteoporosis, type 2 diabetes, hypertension, alzheimer's diseases, Age-Related Macular Degeneration (AMD), stroke, fibrotic diseases, Crohn's disease, and cardiovascular disease; food supplements consisting of amino acids; food supplements consisting of trace elements; vitamin and mineral food supplement; dietetic beverages consisting of vitamins, minerals, amino acids and trace elements; dietetic substances consisting of vitamins, minerals, ani acids and trace elements; mineral food supplements; nutritional supplements for the treatment and relief of cancer, tumors, blood-related diseases, HIV/AIDS, diarrheal diseases, tuberculosis, malaria, measles, pertussis, tetanus, meningitis, syphilis, influenza, viral hepatitis, Hepatitis B, infectious diarrhea, rabies, Japanese encephalitis, tuberculosis, mumpsage-related, osteoarthritis, atherosclerosis diseases, arthritis, cataracts, osteoporosis, type 2 diabetes, hypertension, alzheimer's diseases, Age-Related Macular Degeneration (AMD), stroke, fibrotic diseases, Crohn's disease, and cardiovascular disease

Classification kind code

11

Mark Details

Serial Number

1882947

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 42
on 19th May 2021		Advertised
Submitted for opposition 26
on 23rd Apr 2021		Approved
Submitted for opposition 27
on 23rd Apr 2021		Approval Notice Sent
Submitted for opposition 15
on 23rd Sept 2020		Correspondence Created
Submitted for opposition 15
on 24th Feb 2020		Correspondence Created
Submitted for opposition 22
on 15th May 2019		Search Recorded
Submitted for opposition 20
on 15th May 2019		Examiner's First Report
Submitted for opposition 31
on 16th Feb 2018		Formalized
Submitted for opposition 1
on 14th Feb 2018		Created
Submitted for opposition 30
on 13th Feb 2018		Filed